Rekvina Laboratories Intrinsic Value

Rekvina Laboratories intrinsic value. Rekvina Laboratories (VINRKLB) median intrinsic value is ₹24.05 from 4 valuation models (range ₹24–₹107), vs current price ₹80.17 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit VINRKLB stock price BSE.

Market Price (CMP)
₹80.17
Primary Intrinsic Value
₹24.05
Market Cap
₹24.1 Cr
-70.0% Downside
Median Value
₹24.05
Value Range
₹24 - ₹107
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

VINRKLB Valuation Methods Summary — DCF, Graham Number & P/E

Rekvina Laboratories intrinsic value across 4 models vs current price ₹80.17 — upside/downside and value range per method. Browse VINRKLB cash flow statement for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹24.05 ₹19.24 - ₹28.86 -70.0% EPS: ₹0.36, Sector P/E: 22x
Revenue Multiple Method revenue ₹106.67 ₹96.00 - ₹117.34 +33.1% Revenue/Share: ₹53.33, P/S: 2.0x
PEG Ratio Method growth ₹24.05 ₹21.64 - ₹26.46 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹24.05 ₹21.64 - ₹26.46 -70.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
Method Types: Earnings Asset DCF Growth Dividend Conservative

VINRKLB Intrinsic Value vs Market Price — All Valuation Models

Rekvina Laboratories fair value range ₹24–₹107 vs current market price ₹80.17 across 4 valuation models. Analyse VINRKLB shareholding pattern to track promoter, FII and institutional holdings.

VINRKLB Intrinsic Value Analysis — Undervalued or Overvalued?

Rekvina Laboratories median intrinsic value ₹24.05, current price ₹80.17 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of VINRKLB?

Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Rekvina Laboratories (VINRKLB) is ₹24.05 (median value). With the current market price of ₹80.17, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹24.05 to ₹106.67, indicating ₹24.05 - ₹106.67.

Is VINRKLB undervalued or overvalued?

Based on our multi-method analysis, Rekvina Laboratories (VINRKLB) appears to be trading above calculated value by approximately 70.0%.

VINRKLB Financial Health — Key Ratios vs Industry Benchmarks

Rekvina Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Operating Margin 8.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 16.00x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

VINRKLB Cash Flow Quality — Operating & Free Cash Flow

Rekvina Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10